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ABSTRACT 
 
 
Differential Effects of Stress on a Murine Model of Multiple Sclerosis. (April 2011) 
 
Jessica Jean Heibel 
Department of Veterinary and Biomedical Sciences 
Texas A&M University 
 
Research Advisor: Dr. C. Jane R. Welsh 
Department of Veterinary Integrative Biosciences 
 
Multiple sclerosis (MS) is a demyelinating autoimmune disease that affects the central 
nervous system (CNS) in humans. Several studies have shown a strong correlation 
between stressful events and the onset and exacerbation of MS in patients. Based on this 
information, similar studies have been undertaken in mice. CNS demyelination is 
induced in mice by infecting them with Theiler’s murine encephalomyelitis virus 
(TMEV). After the initial encephalitis phase, the virus persists in susceptible mice 
strains and demyelination of the CNS occurs, creating a useful model of MS. 
Using this model, several types of stress – social, restraint, and handling – have been 
utilized, either prior to infection or concurrently, to study the effects in virus-induced 
demyelination in mice. However, these studies have primarily focused on the effects of 
chronic stress, while the effects of acute stress on a MS model have, for the most part, 
been ignored.  
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The objectives of this experiment are to examine the differences in immune response 
between chronically and acutely stressed mice. Mice in the acute stress group are 
hypothesized to experience an enhanced immune response, which should lead to: better 
viral clearance, smaller and fewer lesions in the CNS, and better physical coordination 
than the chronic stress group.  
 
Mice will be separated into three groups. One group will undergo chronic stress, another 
will undergo acute stress, and the last group will serve as the control. Mice will be 
infected with TMEV and monitored for effects. Weight measurements and behavioral 
scoring will be utilized as a way of monitoring disease progression in live mice.  
Continual monitoring will continue as TMEV is allowed to persist into the chronic, 
demyelinating phase. The mice will be terminated to collect tissue and serum samples 
during this phase.  
 
Since studies comparing immunological effects of acute versus chronic stress have 
consistently shown that immunosuppression is associated with chronic stress, while 
immunoenhancement is associated with acute stress, polar results are also expected in 
this experiment. Following TMEV infection and subsequent CNS demyelination, 
different results between the chronically and acutely stressed mice seem likely.  
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NOMENCLATURE 
 
ARS Acute restraint stress 
BBB Blood brain barrier 
CNS Central nervous system 
CRS Chronic restraint stress 
EBV Epstein-Barr virus 
HLA Human leukocyte antigens 
HPA hypothalamo-pituitary-adrenocortical 
I&D Inflammation and demyelination 
MBP Myelin basic protein 
MHC Major histocompatibility complex  
MOG Myelin oligodendrocyte glycoprotein 
MRI Magnetic resonance imaging 
MS Multiple sclerosis 
NK cell Natural killer cell 
NRS No restraint stress 
PBS Phosphate buffered solution 
PFU Plaque forming units 
PI Post infection 
PPMS Primary progressive multiple sclerosis 
RRMS Relapsing remitting multiple sclerosis 
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RS Restraint stress 
SNS Sympathetic nervous system 
SPMS Secondary progressive multiple sclerosis 
TMEV Theiler’s murine encephalomyelitis virus 
TNFα Tumor necrosis factor alpha 
TVID Theiler’s virus-induced demyelination 
WM White matter 
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CHAPTER I 
INTRODUCTION 
 
Multiple sclerosis 
MS is the most common autoimmune disease of the central nervous system and is 
characterized by demyelination of the CNS. In the United States, approximately 250,000 
to 350,000 people are affected by this disease (Noseworthy et al., 2000). Diagnosis 
typically involves patient history of symptoms and magnetic resonance imaging (MRI) 
to detect lesions, with two possible clinical diagnoses: relapsing-remitting MS (RRMS) 
which is observed in 85-90% of cases, and primary progressive MS (PPMS). Forty 
percent of RRMS cases fail to recover from attacks over time and develop a form of MS 
known as secondary progressive (SPMS) (Hafler, 2004).   
 
Although lesions can be found throughout the CNS, certain areas tend to have a greater 
susceptibility, such as the optic nerve, brainstem, spinal cord, and periventricular 
regions. The current model for acute lesion development suggests that activated CD4+ 
T-cells enter the CNS, creating an autoimmune inflammatory reaction. Antibodies 
against target antigens, such as myelin basic protein (MBP) and myelin oligodendrocyte 
glycoprotein (MOG), are able to infiltrate the CNS due to the T-cells disruption of the 
_______________ 
This thesis follows the style of Brain, Behavior, and Immunity. 
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blood-brain barrier (BBB). Once inside the CNS, these antibodies cause either direct or 
complement-mediated demyelination. Other factors, such as macrophage release of 
tumor necrosis factor alpha (TNF-α) and interferon gamma are believed to amplify the 
immune response (French-Constant, 1994, Noseworthy et al., 2000). 
 
The exact etiology of these events is unclear, but many factors are known - or suspected 
- to be involved in the initiation of MS, including genetic, environmental, and infectious 
agents.  Epidemiological studies show that those of European or Scandinavian descent 
have a greater susceptibility to developing MS as do first-degree relatives of a MS 
patient (Kurtzke, 1991, Ramagopalan and Sadovnick, 2011). As technology has 
advanced, studies have developed a myopic approach and are searching for the specific 
genetic cause of this disease. Currently, the major histocompatibility complex (MHC) 
for human leukocyte antigens (HLA) located on chromosome 6 is believed to be the best 
connection between genetic predisposition and MS (Ramagopalan and Ebers, 2009) 
although other genes encoding receptors may also have an effect. 
 
Environmental factors such as UV-radiation exposure (Sloka et al., 2011), sex 
(Ramagopalan and Sadovnick, 2011), and stress (Ackerman et al., 2002) have long been 
shown to have an effect on disease onset and progression. Epidemiology has been 
especially useful in elucidating the relationship between these factors and MS. For 
example, the inverse correlation between UV exposure and MS prevalence has led to the 
revelation of vitamin D’s importance in delaying or reducing symptoms of MS. Also, 
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sex (characterized as an environmental factor in Ramagopalan’s 2009 paper) has been 
shown to be an important dynamic since females are twice as likely as males to develop 
MS, a trend common in most autoimmune diseases. Finally, stress has probably been the 
first such factor connected with MS. In one of the earliest descriptions of MS, Charcot 
stated that grief, vexation, and adverse changes in social circumstance seemed to be 
connected to the onset of disease (Charcot, 1877). Further studies have proven a 
connection between onset and exacerbation of symptoms both in patients and animal 
models (Ackerman et al., 2002, Mohr et al., 2004). 
 
Infectious agents as a factor in MS development and exacerbation is a topic of debate, 
however, evidence suggests that viruses such as Epstein-Barr (EBV) could play a role by 
activating pathogenic T-cells, causing inflammation and subsequent autoimmunity 
(Franciotta and Lolli, 2005, Lucchinetti et al., 2000). Besides pathological evidence, 
epidemiological and migrational data also support the idea of an infectious agent being 
involved in the onset of MS (Kurtzke and Heltberg, 2001, Sloka et al., 2011). 
 
TMEV as a model of MS 
First described by Max Theiler, Theiler’s murine encephalomyelitis virus causes flaccid 
hind limb paralysis in mice (Theiler, 1934). The virus consists of two subgroups, the 
highly fatal and virulent strains, and the less virulent strains, which includes BeAn. 
Upon intracerebral injection, the BeAn strain causes the acute phase 
polioencephalomyelitis infection after one week. One month post-infection, the chronic 
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phase inflammatory demyelinating disease occurs (Tsunoda and Fujinami, 2010). This 
demyelination is referred to as Theiler’s virus-induced demyelination (TVID), and is 
only seen in susceptible mice such as SJL and CBA strains (Lipton et al., 1986, Tsunoda 
et al., 1996). TVID resembles MS in that inflammatory demyelination occurs in the 
white matter (WM) of the CNS coupled with spastic paralysis. Because of the possible 
involvement of infectious agents in the etiology and exacerbation of MS, TVID has 
become a useful viral model for the manipulation and study of MS (Olson and Miller, 
2009, Sato et al., 2011, Tsunoda and Fujinami, 2010).   
 
Stress 
The role of stress in medicine and science was first introduced by Selye. He described 
stress as the nonspecific response of the body to any demand and the resulting 
pathological results. He also identified the hypothalamo-pituitary-adrenocortical (HPA) 
axis as the primary effector of the stress response, and introduced three phases of stress: 
the alarm, resistance, and exhaustion stages (Selye, 1974). The terms alarm, resistance, 
and exhaustion are synonymous with eustress, resilience, and distress respectively, while 
eustress can also be referred to as acute stress and distress as chronic stress (Dhabhar, 
2009, Dhabhar and McEwen, 1997). Acute stress is defined as stress during a period of 
time lasting only minutes to hours, while stress is considered chronic if it lasts for weeks 
to years (Dhabhar, 2008, Dhabhar and McEwen, 1997, Sheridan et al., 1998). Currently, 
there are four groups of stressors defined: 1) physical stressors such as heat, cold, noise, 
etc. 2) psychological stressors such as anxiety, fear, and frustration 3) social stressors 
  5   
like dominance in animals or divorce and unemployment in humans and 4) exercise, 
orthostasis, hypoglycemia, etc. which challenge homeostasis in the body (Pacak and 
Palkovits, 2001).   
 
According to Dhabar and McEwen, acute stress my result in an immunopreparatory or 
immunoenhancing response, while chronic stress may result in dysregulation or 
suppression of the immune system (Dhabhar and McEwen, 1997). As reviewed by 
Kemeny and Schedlowski, during chronic stress an increased release of glucocorticoids 
due to HPA axis activity coupled with responses of the sympathetic nervous system 
(SNS) lead to a decrease in cellular and humoral immunity. However, acute stress 
activates the immune response with higher numbers of natural killer (NK) cell and 
granulocyte numbers (Kemeny and Schedlowski, 2007). To further elaborate, during 
acute stress, redistribution of leukocytes occurs in the skin and sentinel lymph nodes, 
hormone concentrations are at physiologic stress levels, and the source of 
glucocorticoids remains endogenous, all of which create an immunoenhancing effect. 
Conversely, chronic stress induces immunosuppression with redistribution of immune 
cells to leukocyte-depleted compartments such as the blood, hormone concentrations are 
at extremely high pharmacologic levels, and glucocorticoids are supplied by synthetic 
analogues (Dhabhar, 2008). Psychological factors such as coping, control, and learning, 
along with physiological factors which include genetics, nutrition, sleep, and 
physiological health can influence a person’s response to stress, and if well-developed, 
help maintain homeostasis (Dhabhar, 2009).  
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Science and medicine are interested in the opposing effects between chronic and acute 
stress because of the implications towards infection and disease (Dhabhar, 2009, 
Kemeny and Schedlowski, 2007, Sheridan et al., 1998). Of interest to this study is the 
previously mentioned relationship between stress and the onset and progression of MS 
(Ackerman et al., 2002, Mohr et al., 2004, Warren et al., 1982). Restraint stress (RS) has 
previously been employed with mice to study the effects of chronic stress on the TMEV 
model of MS (Campbell et al., 2001, Steelman et al., 2009). These studies have shown 
an exacerbation of disease symptoms, with increases in number of lesions, macrophage 
infiltration, and clinical severity of disease. (Campbell et al., 2001, Young et al., 2010) 
In this study, we utilized the TMEV model of multiple sclerosis, to examine how the 
effects of chronic versus acute restraint stress prior to infection affect the onset of TVID. 
Because TVID is a viral model of MS, it was hypothesized that the immunoenhancing 
effects of acute stress will lead to better viral clearance in the mice, which will produce 
fewer lesions and a better clinical prognosis than their chronic stress counterparts.   
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CHAPTER II 
METHODS AND MATERIALS 
 
Mice 
A total of 18 three- to five-week-old SJL mice bred in house were used in these 
experiments. These mice were assigned to different types of stress accordingly: 7 
chronic restraint stress (CRS), 7 acute restraint stress (ARS), and 4 no restraint stress 
(NRS).  For this study, all mice were infected with TMEV. Groups were kept in separate 
cages, with females and males also separated, and were fed ad libitum a diet of mouse 
chow containing 9% fat 20.5% protein. Water was also provided ad libitum. All animal 
care protocols were in accordance with NIH guidelines for Care and Use of Laboratory 
Animals and were approved by the Texas A&M University Laboratory Animal Care and 
Use Committee. 
 
 Infection and restraint stress protocol 
 fter anesthesia with isoflurane, mice were injected with  .0   104 plaque forming units 
(PFU) of BeAn strain of TMEV in 20 µL of DMEM media into the right mid-parietal 
cortex at a depth of approximately 1.5 mm (Campbell et al., 2001). 
 
Chronic restraint stress was carried out by placing mice in well-ventilated plastic tubes 
for 8 hours overnight, 5 consecutive nights per week, for a total of 3 weeks (Campbell et 
al., 2001). The tubes were perforated with small holes and internal diameters ranged 
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from 2.0-3.0 cm. Acute restraint stress followed a similar protocol, but mice were only 
restrained once for a period of 2 hours. Infection occurred immediately after the first 
restraint session. NRS mice were infected concurrently with ARS mice.   
 
Clinical scoring and health monitoring 
ARS and NRS mice were monitored daily for 1 week post-infection (PI) and CRS for 3 
weeks PI. After these time periods, mice were clinically assessed on a weekly basis. 
Weights and temperatures were among the data collected during these periods, with a 
time lapse of 3 hours between restraint stress and weighing for CRS mice.  
 
The other set of data collected was clinical scores, which assesses the following 
indicators of health in mice: grooming, ruffling, gait, limb strength, hunched back, 
righting reflex, and general appearance. After considering all of these areas, a single 
score is given for the mouse’s general health. Scores range from 0 to 5, with 0 being a 
healthy, well-groomed, coordinated and active mouse, while a score of 5 indicates severe 
disease with complete lack of grooming and response to stimuli, no mobile ability, and 
spastic, uncoordinated movements. 
 
Termination and histological analysis 
Mice were sacrificed 150-162 days PI using a lethal dose of Beuthanasia special 150 
mg/kg (Steelman et al., 2009), and were perfused first with phosphate-buffered solution 
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(PBS) followed by a 10% solution of formalin in PBS. Mice were examined for any 
gross abnormalities at termination.  
 
After termination, the brains and spinal cords of each mouse were removed, processed, 
and embedded in paraffin. Tissues were sectioned and mounted on individual slides, 
then were stained with hematoxylin and eosin (H&E) for microscopic examination.  
 
Spinal sections were read blinded to condition and scored for signs of inflammation 
(perivascular cuffing, meningitis) and percent demyelination (Sieve et al., 2004).  Scores 
ranged from 0-4 as follows: 0 – lack of inflammation and demyelination (I&D), healthy 
appearance; 1 – I&D present but limited to 25% or less of WM; 2 – I&D present and 
limited to 25-50% of WM; 3 – I&D present and extend from 50-75% of WM; 4 – signs 
of I&D present in 75% or more of section.  
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CHAPTER III 
RESULTS 
 
The effects of restraint stress on clinical scores 
As depicted in Figures 1 and 2, CRS exacerbated symptoms related to the acute phase of 
TVID. Temperatures recorded during the first week PI were lower for all three groups, 
with NRS and ARS mice exhibiting the greatest decrease in temperature. After the first 
week, as Figure 1 shows, temperatures returned to baseline and remained through the 
entire experiment (complete data not shown).  Figure 2 shows the general health scores 
for each group of mice. Scores for CRS mice were elevated compared to ARS and NRS 
mice, which appeared asymptomatic.  
 
During the 3 week RS period, CRS mice exhibited poor grooming, hunched postures, 
and severe signs of encephalitis. One mouse was lost during the week 1of CRS, creating 
n=6 for this group.  
 
RS also caused weight loss in mice during acute phase TVID. CRS appears to have the 
greatest effect on mice, with an average weight loss of almost 30% according to Figure 
3. ARS and NRS also experienced slight weight loss (~15%) but returned to baseline in 
less than 3 weeks PI (CRS mice returned to baseline ~ 1 month PI).  
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During the chronic phase of TVID, as shown in Figure 3, all mice experienced weight 
gain. NRS experienced the greatest percentage increase in weight, for which there is 3 
possible explanations: 1) RS stunted the growth of ARS and CRS mice 2) NRS mice 
were the youngest group at time of infection or 3) the NRS group had the highest ratio of 
males.  
 
Figure 4 displays the general health scores for the entirety of the experiment. As 
expected, CRS mice had the worst symptoms in comparison to ARS and NRS mice. 
Although scores between the ARS and NRS groups are similar, NRS mice appeared to 
develop symptoms of TVID more rapidly than the ARS group between days 45 and 90.  
 
 Histological analysis 
Figure 5 is a shows the relationship between histology and general health scores. As 
expected, the CRS group shows a trend to the upper right corner of the plot, indicating 
severe disease. The histology samples in Figure 6 include one spinal cord section from 
each RS group.  Figure 5-A (CRS) has signs of inflammation, meningitis, and 
demyelination in ~75% of WM, while Figure 5-C (ARS) shows similar signs in ~40% of 
its WM. Figure 5-E (NRS) has the least amount of inflammation and demyelination in 
this sample. 
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CHAPTER IV 
DISCUSSION AND SUMMARY 
  
Multiple studies have been conducted to investigate the role of chronic stress on the 
neuropathogenesis of Theiler’s virus in mice. With each study, chronic stress has led to a 
more severe case of TVID, including decreased body weight and increased clinical 
scores during the acute phase, and higher clinical and histological scores during chronic 
disease (Campbell et al., 2001, Sieve et al., 2004, Steelman et al., 2009, Young et al., 
2010). This reaction is thought to be mediated by a stress-induced immunosuppression, 
which, at the onset of TMEV infection, impairs the immune system’s ability to clear the 
virus (Campbell et al., 2001). The virus then replicates to higher levels in the CNS 
resulting in increased demyelinating disease. 
 
Acute stress enhances the immune system (Dhabhar, 2009, Tsunoda et al., 1996), and we 
predicted that acute stress prior to Theiler’s virus infection would have a protective 
effect on the disease progression, due to increased viral clearance.  Data collected during 
acute phase TVID indicated that acutely stressed mice were less affected by Theiler’s 
virus than the chronically stressed mice. Chronically stressed mice also experienced a 
greater percentage of weight loss and higher general health scores, while non-stressed 
and acutely stressed mice data were similar.  
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For chronic phase TVID, general health scores were similar to those noted in the acute 
phase in that the chronically stressed mice were more severely affected. The acutely- and 
non-stressed mice had similar responses. One important difference between the non-
stressed and acutely stressed groups: the clinical scores of the non-stressed mice 
worsened at a faster rate than the acutely stressed mice’s between days 4  and 90. This 
period is when chronic phase symptoms first became apparent, so this leads to the 
hypothesis that ARS mice did mount an enhanced immune response, which allowed 
improved viral clearance and slower disease progression.  
 
When examining histological scores versus final scores for general health, similar trends 
are once again evident. Considering data of each group, plotted towards the top right 
corner (indicating most severe disease) is the results of CRS mice. Non-stressed and 
acutely stressed mice once again show less severe trends, and when compared with each 
other, the acutely stressed group (excluding outliers) developed the least severe disease. 
However, preliminary examination of the histology indicated more inflammation and 
less demyelination in acutely stressed mice.  
 
A weakness in this study was small sample size and lack of statistical analysis and so 
conclusions drawn are less conservative than desired. Serum was also collected 
throughout the experiment and stored. Future analysis for GC levels or antibodies could 
further elucidate differences between the three RS groups. However, based on these 
results, acute and chronic stress do produce divergent effects in the TMEV model of MS. 
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Chronic stress is known to cause immunosuppression which impairs the ability to mount 
an effective immune response to viruses, leading to more severe disease. Acute stress 
should enhance the ability to clear virus by its immunoenhancing effects. In this study, 
the clinical observations support this hypothesis in that the acutely stressed mice had a 
delayed onset of demyelinating disease symptoms. Relating these findings to multiple 
sclerosis, chronic stress at the time of infection with a pathogen would cause 
immunosuppression and allow the virus to replicate to higher levels and cause worse late 
disease. In contrast, acute stress may prove protective in the development of disease. The 
implication of this study could provide further understanding into how stress may play a 
role in the onset and establishment of autoimmune disease. 
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